NYSE | TSX : ACB
EDMONTON, Sept. 4, 2019 /CNW/ - Aurora Cannabis Inc.
("Aurora or the "Company") (NYSE | TSX: ACB), the Canadian company
defining the future of cannabis worldwide, announced today that on
September 3, 2019, Aurora disposed of
its remaining 28,833,334 shares, representing 10.5% of the issued
and outstanding shares of The Green Organic Dutchman Holdings Ltd
("TGOD"), at a price of $3.00 per
share for aggregate gross proceeds of $86.5
million. The completion of the sale of TGOD shares
represents an approximate 50% internal rate of return for the
Company. As a result of this transaction, Aurora no longer holds
any shares of TGOD, however does continue to hold warrants to
purchase 16,666,667 shares of TGOD.
"Aurora has a broad portfolio of strategic investments that
allow us to participate in opportunities throughout the cannabis
sector, while providing the company with non-dilutive access to
capital," said Terry Booth, CEO of
Aurora. "We evaluate our investment portfolio on a regular basis to
make sure it continues to align with our investment strategy and
corporate priorities. When we acquired Whistler Medical Marijuana
Corporation – an iconic and premium organic cannabis producer – our
interest in TGOD became less important to our core strategy. Our
return on our TGOD investment is significant and will add
non-dilutive capital and further enhance our strategy to remain a
dominant force in the global cannabis industry."
For further details, please see the early warning report, a copy
of which will be available on TGOD's profile on SEDAR at
www.sedar.com.
About Aurora
Headquartered in Edmonton, Alberta,
Canada with funded capacity in excess of 625,000 kg per
annum and sales and operations in 25 countries across five
continents, Aurora is one of the world's largest and leading
cannabis companies. Aurora is vertically integrated and
horizontally diversified across every key segment of the value
chain, from facility engineering and design to cannabis breeding
and genetics research, cannabis and hemp production, derivatives,
high value-add product development, home cultivation, wholesale and
retail distribution.
Highly differentiated from its peers, Aurora has established a
uniquely advanced, consistent and efficient production strategy,
based on purpose-built facilities that integrate leading-edge
technologies across all processes, defined by extensive automation
and customization, resulting in the massive scale production of
high-quality consistent product. Designed to be replicable and
scalable globally, our production facilities are designed to
produce cannabis at significant scale, with high quality,
industry-leading yields, and low-per gram production costs. Each of
Aurora's facilities is built to meet European Union Good
Manufacturing Practices ("EU GMP") standards. Certification has
been granted to Aurora's first production facility in Mountain View
County, the MedReleaf Markham facility, and its wholly owned
European medical cannabis distributor Aurora Deutschland. All
Aurora facilities are designed and built to the EU GMP
standard.
In addition to the Company's rapid organic growth and strong
execution on strategic M&A, which to date includes 17 wholly
owned subsidiary companies – MedReleaf, CanvasRX, Peloton
Pharmaceutical, Aurora Deutschland, H2 Biopharma, BC Northern
Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia,
HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs,
Whistler, Chemi Pharmaceutical, and Hempco – Aurora is
distinguished by its reputation as a partner and employer of choice
in the global cannabis sector, having invested in and established
strategic partnerships with a range of leading innovators,
including: Radient Technologies Inc. (TSXV: RTI), Cann Group Ltd.
(ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom
Holdings Inc. (CSE: CHOO), CTT Pharmaceuticals (OTCC: CTTH),
Alcanna Inc. (TSX: CLIQ), High Tide Inc. (CSE: HITI), EnWave
Corporation (TSXV: ENW), Capcium Inc. (private), Evio Beauty Group
(private), and Wagner Dimas (private).
Aurora's Common Shares trade on the TSX and NYSE under the
symbol "ACB", and is a constituent of the S&P/TSX Composite
Index.
For more information about Aurora, please visit our investor
website, investor.auroramj.com
Terry Booth, CEO
Aurora Cannabis Inc.
Forward looking statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither the TSX, NYSE nor their Regulation Services Provider
(as that term is defined in the policies of the TSX and NYSE)
accepts responsibility for the adequacy or accuracy of this
release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/aurora-cannabis-announces-sale-of-remaining-shares-in-the-green-organic-dutchman-sale-of-non-core-holdings-raises-gross-proceeds-of-86-5-million-300911364.html
SOURCE Aurora Cannabis Inc.